Epidemiology of Hepatitis B, C and Delta in Reunion Island

• Conditions: Hepatitis B; Hepatitis C; Hepatitis D

• Registration Number: NCT03362866
• Lead Sponsor: Centre Hospitalier Universitaire de la Réunion

Brief Summary

Viral hepatitis B, C and Δ represent a global public health problem for which France was very early mobilized. Despite this, in its foreword, the Dhumeaux report on "Management of people infected with hepatitis B or hepatitis C viruses" identifies a residual area of weakness in this care that is the incomplete regional epidemiological data in the Overseas Territories. The specific ethno-socio-cultural characteristics of these territories make it difficult to transpose data from the mainland France. This study aims at improving our knowledge on the characteristics of patients with hepatitis B, C and Δ in Reunion Island, their follow-up, their evolution and complications.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2017-11-24
• Study First Submitted QC: 2017-11-29
• Study First Posted: 2017-12-05
• Status Verified: 2018-09
• Last Update Submitted: 2018-09-04
• Last Update Posted: 2018-09-05
• Study Start: 2019-01
• Primary Completion: 2023-04
• Study Completion: 2023-04

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Major patient

• with confirmed HBsAg and / or anti HCV positive Ab
• residing in Reunion Island
• followed in one of the participating centers

Exclusion Criteria

• Patient carrying isolated anti HBc antibodies

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients with hepatitis B, C and Δ in Reunion	Up to 5 years	Hepatitis diagnosis will be made according to the ongoing guidelines in France (referred by the National AIDS and Hepatitis Research Agency (ANRS)